Fenofibrate

How Does Fenofibrate Work?

Fenofibrate is a prodrug that is converted in the body to its active form, fenofibric acid, which activates a protein receptor in liver cells called peroxisome proliferator-activated receptor alpha (PPARα). This activation triggers multiple simultaneous effects on how the body processes fats.

By activating PPARα, fenofibrate increases the activity of lipoprotein lipase (the enzyme that breaks down triglycerides), reduces production of apolipoprotein C-III (which normally slows fat breakdown), decreases VLDL production in the liver, and increases synthesis of the proteins that build HDL cholesterol particles. The net result is a 30-50% reduction in triglycerides, 10-20% increase in HDL, and variable LDL reduction depending on the patient's baseline lipid profile.

Unlike statins, which block cholesterol production, fenofibrate accelerates the clearance and breakdown of triglycerides from the bloodstream. This mechanism makes fenofibrate particularly valuable for patients with atherogenic dyslipidemia — the pattern of high triglycerides and low HDL common in metabolic syndrome and type 2 diabetes.

How Hard Is It to Find Fenofibrate in Stock?

Fenofibrate is generally available in 2026 — the FDA has not declared a national shortage. As a generic drug with multiple manufacturers, national supply is considered stable. However, patients regularly encounter pharmacy-level stock-outs due to the wide variety of formulations (10+ strengths in tablets and capsules), pharmacy-specific supplier contracts, and occasional manufacturer delays.

The most commonly available formulations are generic fenofibrate 145 mg and 160 mg tablets. Less common strengths (40 mg, 50 mg, 150 mg, 200 mg in specific brands) may be harder to locate at individual retail pharmacies. Brand-name versions like Tricor and Lipofen have very limited retail availability.

If your pharmacy is out of your specific fenofibrate strength, medfinder can help. You provide your medication, dose, and zip code, and medfinder calls pharmacies near you to find which ones can fill your prescription. Results are texted directly to you.

Who Can Prescribe Fenofibrate?

Fenofibrate is not a controlled substance, so any licensed prescriber can write a prescription for it. There are no DEA requirements, special certifications, or mandatory in-person visit requirements.

• Primary care physicians (PCPs) — most patients get their fenofibrate prescription from their family doctor or internist
• Cardiologists — manage complex lipid disorders and patients with cardiovascular disease
• Endocrinologists — prescribe for patients with diabetes and associated metabolic dyslipidemia
• Lipid specialists (clinical lipidologists) — for complex cases including familial hypercholesterolemia
• Nurse practitioners (NPs) and physician assistants (PAs) — full prescribing authority in most states

Fenofibrate is fully available via telehealth in all 50 states. Telehealth platforms including Teladoc, MDLive, and insurance-linked portals can connect patients with a prescriber quickly. You will typically need a recent lipid panel (cholesterol and triglyceride results) to complete the telehealth visit.

Is Fenofibrate a Controlled Substance?

No. Fenofibrate is not a controlled substance and has no DEA schedule. It has no abuse potential or dependence risk. Any licensed prescriber — including nurse practitioners and physician assistants — can prescribe fenofibrate, and it can be prescribed via telehealth in all 50 states without an in-person visit requirement.

There are no quantity limits imposed by the DEA, and you can receive a 90-day supply at once through mail-order or preferred retail pharmacies. Refills can be sent electronically by your prescriber without a new paper prescription each time.

Common Side Effects of Fenofibrate

Most patients tolerate fenofibrate well. Common side effects include:

• Abdominal pain, nausea, or indigestion (take with food for brands that require it)
• Back pain
• Headache
• Liver enzyme elevations (monitored with periodic blood tests)
• Upper respiratory infection symptoms

Serious side effects — call your doctor immediately or seek emergency care if you experience:

• Unexplained muscle pain, weakness, or tenderness (especially with dark urine) — possible rhabdomyolysis
• Signs of liver damage: jaundice, dark urine, severe right upper abdominal pain
• Gallstone symptoms: sharp upper right abdominal pain after meals
• Signs of blood clots: leg swelling/pain, chest pain, shortness of breath
• Severe skin reactions (blistering, peeling): possible Stevens-Johnson syndrome or toxic epidermal necrolysis

Final Thoughts on Fenofibrate

Fenofibrate is a well-established, affordable generic medication that remains an important tool for managing high triglycerides and mixed dyslipidemia in 2026. While the 2025 FDA labeling update clarified that it does not provide the same cardiovascular risk reduction as statins, it continues to be the preferred fibrate for patients already on statin therapy and the first-line treatment for severe hypertriglyceridemia and pancreatitis prevention.

With generic prices as low as $9-$19 for 90 tablets using discount cards, and wide availability at most large pharmacies, cost and access barriers are generally low for most patients. The main challenge is navigating the many formulations and strengths to find the exact dose in stock at a pharmacy near you.

If you are having trouble finding fenofibrate in stock, medfinder can help. Enter your medication details and zip code, and medfinder will call pharmacies near you to find out which ones can fill your prescription. Results are texted directly to you — no hold music, no wasted trips.